Loading
Latest filing published 30 Jan 2026 for CARLSMED, INC.. Read the official filing
No signal scores available.
Niall Casey discloses dealings in Carlsmed, Inc. to SEC (Form 4). In total, 2 filings cover trades dated from 24 July 2025 to 28 January 2026.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
On 30 January 2026 came the latest disclosure, a share grant in Carlsmed, Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations